AI is rewriting biotech’s commercial playbook—cutting waste, shrinking teams, and giving first‑time drugmakers a faster, ...

By freeing enzyme-driven chemical reactions from the limitations imposed by cells, exozyme biosolutions eliminate the scaling bottleneck that has hampered commercial success in the synthetic biology ...

West Pharmaceutical Services, Inc. (NYSE:WST) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, the governing body of West Pharmaceutical Services, Inc. (NYSE ...

We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on HalfBakedInnovations’s Substack by Biotech Distilled. In ...

Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to advance VIR-5500, an ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

ORIC Pharmaceuticals (ORIC) is back on investors’ radar after reporting Phase 1b data for rinzimetostat and enozertinib in difficult to treat cancers, alongside raising US$264 million, which extends ...

Unnatural Products is proving to be a natural at securing partnerships, this time linking up with Novartis in a deal that could garner up to $1.7 billion in biobucks.

A key insight from the whitepaper is the increasing divergence in verification expectations between regions. While the EU requires product verification prior to dispensing, the U.S. system relies on ...

Pharmaceutical sales in the UK are undergoing a gradual but meaningful shift in who represents medicines to healthcare ...

The Evolving Landscape of Pharmaceutical Wastewater Management The global pharmaceutical industry is currently navigating a period of significant transition, where environmental compliance has moved ...